Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital Huddinge, SE-141 86 Stockholm, Sweden.
Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, SE-141 83 Stockholm, Sweden.
Sci Adv. 2024 Jan 5;10(1):eadi2689. doi: 10.1126/sciadv.adi2689. Epub 2024 Jan 3.
Defects in adipocyte lipolysis drive multiple aspects of cardiometabolic disease, but the transcriptional framework controlling this process has not been established. To address this, we performed a targeted perturbation screen in primary human adipocytes. Our analyses identified 37 transcriptional regulators of lipid mobilization, which we classified as (i) transcription factors, (ii) histone chaperones, and (iii) mRNA processing proteins. On the basis of its strong relationship with multiple readouts of lipolysis in patient samples, we performed mechanistic studies on one hit, , which encodes the zinc finger protein 189. Using mass spectrometry and chromatin profiling techniques, we show that ZNF189 interacts with the tripartite motif family member TRIM28 and represses the transcription of an adipocyte-specific isoform of phosphodiesterase 1B (PDE1B2). The regulation of lipid mobilization by ZNF189 requires PDE1B2, and the overexpression of PDE1B2 is sufficient to attenuate hormone-stimulated lipolysis. Thus, our work identifies the ZNF189-PDE1B2 axis as a determinant of human adipocyte lipolysis and highlights a link between chromatin architecture and lipid mobilization.
脂肪细胞脂解缺陷可驱动多种心血管代谢疾病,但控制这一过程的转录框架尚未建立。为解决这一问题,我们在原代人脂肪细胞中进行了靶向扰动筛选。我们的分析确定了 37 个脂质动员的转录调节剂,我们将其分类为 (i) 转录因子、(ii) 组蛋白伴侣和 (iii) mRNA 加工蛋白。基于其与患者样本中脂解的多个指标的强烈关系,我们对一个命中靶点进行了机制研究,该靶点编码锌指蛋白 189。通过质谱和染色质分析技术,我们表明 ZNF189 与三联基序家族成员 TRIM28 相互作用,并抑制磷酸二酯酶 1B 的一种脂肪细胞特异性同工型(PDE1B2)的转录。ZNF189 对脂质动员的调节需要 PDE1B2,而过表达 PDE1B2 足以减弱激素刺激的脂解。因此,我们的工作确定了 ZNF189-PDE1B2 轴作为人类脂肪细胞脂解的决定因素,并强调了染色质结构与脂质动员之间的联系。